These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 38575001)
1. Levosimendan in cardiac amyloidosis: Unveiling promising paths. Faggiano A; Carugo S; Sinagra G; Merlo M Int J Cardiol; 2024 Jul; 406():131994. PubMed ID: 38575001 [No Abstract] [Full Text] [Related]
2. Safety and efficacy of levosimendan in patients with cardiac amyloidosis. Aimo A; Arzilli C; Castiglione V; Morfino P; Panichella G; Passino C; Vergaro G; Emdin M Int J Cardiol; 2024 Jun; 405():131963. PubMed ID: 38479497 [TBL] [Abstract][Full Text] [Related]
3. Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application. Yang F; Zhao LN; Sun Y; Chen Z J Int Med Res; 2019 May; 47(5):1817-1828. PubMed ID: 30958071 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of levosimendan in patients with cardiac amyloidosis. Aimo A; Rapezzi C; Arzilli C; Vergaro G; Emdin M Eur J Intern Med; 2020 Oct; 80():114-116. PubMed ID: 32631802 [No Abstract] [Full Text] [Related]
5. Levosimendan as Rescue Therapy for Acute Heart Failure in a Patient with Duchenne Muscular Dystrophy. Sumanaru D; Josseran L; Essid A; Mbieleu B; Haegy I; Bergounioux J Pediatr Cardiol; 2019 Mar; 40(3):668-670. PubMed ID: 30796500 [TBL] [Abstract][Full Text] [Related]
6. Levosimendan And Septic Cardiomyopathy: A Key That May Have Found Its Lock? Radosevich M; Couture EJ; Nabzdyk C J Cardiothorac Vasc Anesth; 2023 Mar; 37(3):350-352. PubMed ID: 36609077 [No Abstract] [Full Text] [Related]
7. Effects of levosimendan for perioperative cardiovascular dysfunction in patients receiving cardiac surgery: a meta-analysis with trial sequential analysis. Lee CT; Lin YC; Yeh YC; Chen TL; Chen CY Intensive Care Med; 2017 Dec; 43(12):1929-1930. PubMed ID: 28884347 [No Abstract] [Full Text] [Related]
8. Levosimendan as bridge to transplant in patients with advanced heart failure. Ponz de Antonio I; de Juan Bagudá JS; Rodríguez Chaverri A; García-Cosío Carmena MD; Arribas Ynsaurriaga F; Delgado Jiménez JF Rev Esp Cardiol (Engl Ed); 2020 May; 73(5):422-424. PubMed ID: 32061565 [No Abstract] [Full Text] [Related]
10. Levosimendan as rescue therapy in low output syndrome after cardiac surgery: effects and predictors of outcome. Beiras-Fernandez A; Kornberger A; Oberhoffer M; Kur F; Weis M; Vahl CF; Weis F J Int Med Res; 2019 Aug; 47(8):3502-3512. PubMed ID: 30909776 [TBL] [Abstract][Full Text] [Related]
14. High effectiveness of repeated levosimendan cycles in a patient with advanced heart failure. Rodríguez-Santamarta M; Sayago I; López J Med Clin (Barc); 2017 Sep; 149(5):226. PubMed ID: 28641880 [No Abstract] [Full Text] [Related]
15. Levosimendan in patients with low cardiac output syndrome undergoing cardiac surgery: A systematic review and meta-analysis. Zhu J; Zhang Y; Chen L; He Y; Qing X Anaesth Crit Care Pain Med; 2019 Jun; 38(3):243-249. PubMed ID: 30342103 [TBL] [Abstract][Full Text] [Related]
16. Levosimendan use in patients with preoperative low ejection fraction undergoing cardiac surgery: A systematic review with meta-analysis and trial sequential analysis. Ng KT; Chan XL; Tan W; Wang CY J Clin Anesth; 2019 Feb; 52():37-47. PubMed ID: 30172838 [TBL] [Abstract][Full Text] [Related]
17. Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: a prospective randomized controlled trial. Wang A; Cui C; Fan Y; Zi J; Zhang J; Wang G; Wang F; Wang J; Tan Q Crit Care; 2019 Dec; 23(1):428. PubMed ID: 31888711 [TBL] [Abstract][Full Text] [Related]